http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-105820973-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12R2001-43 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N1-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N1-205 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-74 |
| classificationIPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12R1-43 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N1-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-74 |
| filingDate | 2016-03-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2019-08-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2019-08-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-105820973-B |
| titleOfInvention | A kind of Serratia marcescens bacterin vaccine and its preparation method and application |
| abstract | The invention discloses a Serratia marcescens bacterin, the active ingredient of which is a biologically pure culture of Serratia marcescens; the Serratia marcescens has been preserved in the China Microorganism Culture Collection Center, the preservation number is CGMCC NO.11987. The present invention also discloses a preparation method of the Serratia marcescens bacterin, which is obtained from the above-mentioned biologically pure culture of Serratia marcescens through an appropriate separation method; the appropriate separation method is: 4000- Centrifuge at 6000rpm for 30‑60min, discard the supernatant, inactivate the precipitate, centrifuge again, discard the supernatant, wash, centrifuge to precipitate, and prepare. The product produced by the preparation method of the invention has stable yield, good reproducibility, strong anti-tumor effect, strong spleen activation, and other indicators all meet the requirements of quality standards. The Serratia marcescens vaccine provided by the invention has obvious preventive and therapeutic effects on various solid tumors; moreover, the Serratia marcescens vaccine is an inactivated vaccine, which is safe and has no toxic or side effects . |
| priorityDate | 2016-03-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 65.